These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21710497)

  • 1. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
    Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
    Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.
    Tanaka T; Huang J; Hirai S; Kuroki M; Kuroki M; Watanabe N; Tomihara K; Kato K; Hamada H
    Clin Cancer Res; 2006 Jun; 12(12):3803-13. PubMed ID: 16778108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
    Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR
    Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.
    Seo E; Abei M; Wakayama M; Fukuda K; Ugai H; Murata T; Todoroki T; Matsuzaki Y; Tanaka N; Hamada H; Yokoyama KK
    Cancer Res; 2005 Jan; 65(2):546-52. PubMed ID: 15695398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.
    Haisma HJ; Pinedo HM; Rijswijk A; der Meulen-Muileman I; Sosnowski BA; Ying W; Beusechem VW; Tillman BW; Gerritsen WR; Curiel DT
    Gene Ther; 1999 Aug; 6(8):1469-74. PubMed ID: 10467371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural cell adhesion molecule 2 as a target molecule for prostate and breast cancer gene therapy.
    Takahashi S; Kato K; Nakamura K; Nakano R; Kubota K; Hamada H
    Cancer Sci; 2011 Apr; 102(4):808-14. PubMed ID: 21214674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer.
    Zhang Y; Qin X; Zhang Y; Zhao L; Wang Y; Liu X; Yao L
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):219-26. PubMed ID: 17632733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropism.
    Heideman DA; van Beusechem VW; Offerhaus GJ; Wickham TJ; Roelvink PW; Craanen ME; Pinedo HM; Meijer CJ; Gerritsen WR
    Hum Gene Ther; 2002 Sep; 13(14):1677-85. PubMed ID: 12396621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of target molecules for prostate cancer gene therapy.
    Suzuki K; Nakamura K; Kato K; Hamada H; Tsukamoto T
    Prostate; 2007 Aug; 67(11):1163-73. PubMed ID: 17516570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
    Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors.
    Oonuma M; Sunamura M; Motoi F; Fukuyama S; Shimamura H; Yamauchi J; Shibuya K; Egawa S; Hamada H; Takeda K; Matsuno S
    Int J Cancer; 2002 Nov; 102(1):51-9. PubMed ID: 12353234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
    Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
    Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
    Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A
    Clin Cancer Res; 2004 Nov; 10(22):7738-46. PubMed ID: 15570008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein.
    de Graaf M; Pinedo HM; Oosterhoff D; van der Meulen-Muileman IH; Gerritsen WR; Haisma HJ; Boven E
    Hum Gene Ther; 2004 Mar; 15(3):229-38. PubMed ID: 15018732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.